Bridge Bank Provides $5MM Debt Financing to CytoSorbents
CytoSorbents received $5 million in non-dilutive debt financing under the terms of the fourth amendment to its amended and restated loan and security agreement with Bridge Bank.
January 3, 2023
Bill Wickline | Bridge Bank | CytoSorbents | Kathleen P. Bloch
Ian Koplin